Already have an account?
Sign InNew customer?
Start hereNote: Availability varies. Contact us to inquire status.
First FDA-approved treatment for equine protozoal myeloencephalitis (EPM). is indicated as an aid in reducing the clinical severity of Equine Protozoal Myeloencephalitis (EPM) caused by Sarcocystis neurona in horses; it is expected that approximately two horses out of three will respond favourably to treatment. One 127 g syringe ONLY.
This product is not eligible for any discounts.
Item | 22-2201 |
---|